ANTI-SYNTHETASE SYNDROME
Clinical trials for ANTI-SYNTHETASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTI-SYNTHETASE SYNDROME trials appear
Sign up with your email to follow new studies for ANTI-SYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR t cells take on muscle disease: new hope for myositis patients
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active inflammatory muscle diseases (myositis). The treatment uses a patient's own immune cells, modified to target and destroy certain immune cells that cause the disease. The goal is to see if it is safe and can r…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Patients take the lead: rare disease study puts your voice first
Knowledge-focused Recruiting nowThis study asks 700 people with rare myositis diseases (and their caregivers) what research questions matter most to them. Through online surveys and forums, the goal is to create a patient-driven list of priorities to guide scientists and funders. No treatments are tested—this i…
Matched conditions: ANTI-SYNTHETASE SYNDROME
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC